X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with Zydus Wellness - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs ZYDUS WELLNESS - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER ZYDUS WELLNESS GSK CONSUMER/
ZYDUS WELLNESS
 
P/E (TTM) x 43.3 45.7 94.7% View Chart
P/BV x 9.1 8.6 105.7% View Chart
Dividend Yield % 1.0 0.5 199.3%  

Financials

 GSK CONSUMER   ZYDUS WELLNESS
EQUITY SHARE DATA
    GSK CONSUMER
Mar-17
ZYDUS WELLNESS
Mar-17
GSK CONSUMER/
ZYDUS WELLNESS
5-Yr Chart
Click to enlarge
High Rs6,551926 707.3%   
Low Rs4,921712 691.6%   
Sales per share (Unadj.) Rs947.8110.2 860.0%  
Earnings per share (Unadj.) Rs156.128.5 548.2%  
Cash flow per share (Unadj.) Rs171.430.3 565.4%  
Dividends per share (Unadj.) Rs70.006.50 1,076.9%  
Dividend yield (eoy) %1.20.8 153.7%  
Book value per share (Unadj.) Rs742.4145.3 510.9%  
Shares outstanding (eoy) m42.0639.07 107.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.17.4 81.4%   
Avg P/E ratio x36.728.8 127.8%  
P/CF ratio (eoy) x33.527.0 123.9%  
Price / Book Value ratio x7.75.6 137.1%  
Dividend payout %44.822.8 196.5%   
Avg Mkt Cap Rs m241,26531,994 754.1%   
No. of employees `0003.80.3 1,442.0%   
Total wages/salary Rs m4,580455 1,007.5%   
Avg. sales/employee Rs Th10,471.416,309.5 64.2%   
Avg. wages/employee Rs Th1,203.11,722.0 69.9%   
Avg. net profit/employee Rs Th1,724.94,215.2 40.9%   
INCOME DATA
Net Sales Rs m39,8654,306 925.9%  
Other income Rs m2,439326 747.2%   
Total revenues Rs m42,3034,632 913.3%   
Gross profit Rs m8,335991 841.3%  
Depreciation Rs m64272 896.4%   
Interest Rs m286 505.5%   
Profit before tax Rs m10,1041,240 814.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,537127 2,781.0%   
Profit after tax Rs m6,5671,113 590.1%  
Gross profit margin %20.923.0 90.9%  
Effective tax rate %35.010.3 341.3%   
Net profit margin %16.525.8 63.7%  
BALANCE SHEET DATA
Current assets Rs m41,4465,162 802.9%   
Current liabilities Rs m16,0111,135 1,411.3%   
Net working cap to sales %63.893.5 68.2%  
Current ratio x2.64.6 56.9%  
Inventory Days Days4227 156.2%  
Debtors Days Days293 858.2%  
Net fixed assets Rs m5,3621,027 522.3%   
Share capital Rs m421391 107.7%   
"Free" reserves Rs m30,8065,287 582.7%   
Net worth Rs m31,2275,678 550.0%   
Long term debt Rs m00-   
Total assets Rs m49,6026,868 722.2%  
Interest coverage x364.5226.5 160.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 128.2%   
Return on assets %13.316.3 81.7%  
Return on equity %21.019.6 107.3%  
Return on capital %32.421.9 147.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2,5910-   
Fx outflow Rs m2824 7,819.4%   
Net fx Rs m2,310-4 -64,161.7%   
CASH FLOW
From Operations Rs m6,225770 809.0%  
From Investments Rs m-6,218-721 862.9%  
From Financial Activity Rs m-3,615-62 5,821.1%  
Net Cashflow Rs m-3,608-13 27,538.9%  

Share Holding

Indian Promoters % 0.0 72.5 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 7.9 10.1%  
FIIs % 12.0 7.9 151.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 11.7 126.5%  
Shareholders   26,457 37,518 70.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   BRITANNIA  NESTLE  LAKSHMI OVERSEAS IND.  DABUR  RUCHI SOYA INDUSTRIES  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

Bajaj Corp: Slow Recovery from GST Implementation (Quarterly Results Update - Detailed)

Nov 10, 2017

A slow recovery from GST implementation and strained wholesale volumes puts pressure on Bajaj Corp's revenues.

ITC: GST Cess Weighs on Cigarettes (Quarterly Results Update - Detailed)

Nov 7, 2017

Additional cess in the GST regime hurts ITC's cigarette business.

Prataap Snacks Ltd. (IPO)

Sep 21, 2017

Is the Prataap Snacks IPO worth your attention?

Apex frozen food Ltd. (IPO)

Aug 21, 2017

Should you subscribe to the IPO of Apex Frozen Foods Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Feb 23, 2018 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS